New uses

For many years, Canadian clinicians have reported Prevora quickly treats bleeding and inflammation in the mouth, as well as
protecting the patient from dental decay.

CHX is pursuing this additional treatment effect with several observation studies and with a controlled study of Canadian seniors. The company intends to apply for an extended indication for Prevora’s use in managing periodontal disease when these studies are completed.

Prevora’s unique combination treatment effect for both dental decay and periodontal disease offers significant benefits to the clinician, the patient and the third-party payer or insurer.